A gas-inducible expression system in HEK.EBNA cells applied to controlled proliferation studies by expression of p27Kip1

Biotechnology and Bioengineering

Volumn 96, Issue 6, 2007, Pages 1155-1166

  Werner, Nicola Susann ^a   Weber, Wilfried ^b   Fussenegger, Martin ^b   Geisse, Sabine ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

^b ETH ZURICH   (Switzerland)

Author keywords

Acetaldehyde; AIR technology; Cell cycle arrest; Controlled proliferation; Genetic engineering; HEK.EBNA cells; Inducible gene expression; p27Kip1

Indexed keywords

ALDEHYDES; ENZYMES; GENE EXPRESSION; GENETIC ENGINEERING; GROWTH (MATERIALS);

ACETALDEHYDE; AIR TECHNOLOGY; CELL CYCLE ARREST; CONTROLLED PROLIFERATION; INDUCIBLE GENE EXPRESSION;

CELL PROLIFERATION;

ACETALDEHYDE; ALKALINE PHOSPHATASE; CYCLIN DEPENDENT KINASE INHIBITOR 1B;

ARTICLE; BIOENGINEERING; CELL CULTURE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MEDICAL TECHNOLOGY; PLASMID; PROTEIN EXPRESSION;

ACETALDEHYDE; ALKALINE PHOSPHATASE; BIOREACTORS; CELL LINE; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; G1 PHASE; GENE EXPRESSION REGULATION; HUMANS; KIDNEY; PROLIFERATING CELL NUCLEAR ANTIGEN; RECOMBINANT PROTEINS; TRANSGENES; VIRAL PROTEINS;

MAMMALIA;

EID: 34247497302     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.21235     Document Type: Article

References (60)

1. Ackland-Berglund CE, Leib DA. 1995. Efficacy of tetracycline-controlled gene expression is influenced by cell type. Biotechniques 18:196-200.
2. A-Mohammadi S, Alvarez-Vallina L, Ashworth LJ, Hawkins RE. 1997. Delay in resumption of the activity of tetracycline-regulatable promoter following removal of tetracycline analogues. Gene Ther 4:993-997.
3. Arany Z, Newsome D, Oldread E, Livingston DM, Eckner R. 1995. A family of transcriptional adaptor proteins targeted by the E1A oncoprotein. Nature 374:81-84.
4. Baron U, Bujard H. 2000. Tet repressor-based system for regulated gene expression in eukaryotic cells: Principles and advances. Methods Enzymol 327:401-421.
5. Beerli RR, Schopfer U, Dreier B, Barbas CF. 2000. Chemically regulated zinc finger transcription factors. J Biol Chem 275:32617-32627.
6. CIP1- arrested CHO cells. Biotechnol Bioeng 85:741-749.
7. Boorsma M, Nieba L, Roller D, Bachmann MF, Bailey JE, Renner WA. 2000. A temperature-regulated replicon-based DNA expression system. Nat Biotechnol 18:429-432.
8. Boorsma M, Hoenke S, Marrero A, Fischer R, Bailey JE, Renner WA, Bachmann MF. 2002. Bioprocess applications of a Sindbis virus-based temperature- inducible expression system. Biotechnol Bioeng 79:602-609.
9. Braselmann S, Graninger P, Busslinger M. 1993. A selective transcriptional induction system for mammalian cells based on Gal4-estrogen receptor fusion proteins. Proc Natl Acad Sci USA 90:1657-1661.
10. Carvalhal AV, Santos SS, Calado J, Haury M, Carrando MJ. 2003. Cell growth arrest by nucleotides, nucleosides and bases as a tool for improved production of recombinant proteins. Biotechnol Prog 19:69-83.
11. Eckner R, Ewen ME, Newsome D, Gerdes M, DeCaprio JA, Lawrence JB, Livingston DM, 1994. Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev 8: 869-884.
12. Felenbok B, Sequeval D, Mathieu M, Sibley S, Gwynne DI, Davies RW. 1988. The ethanol regulon in Aspergillus nidulans: Characterization and sequence of the positive regulatory gene alcR. Gene 73:385-396.
13. Flipphi M, Kocialkowska J, Felenbok B. 2002. Characteristics of physiological inducers of the ethanol utilization (alc) pathway in Aspergillus nidulans. Biochem J 364:25-31.
14. Freundlieb S, Baron U, Bonin AL, Gossen M, Bujard H. 1997. Use of tetracycline-controlled gene expression systems to study mammalian cell cycle. Methods Enzymol 283:159-173.
15. Freundlieb S, Schirra-Muller C, Bujard H. 1999. A tetracycline controlled activation/repression system with increased potential for gene transfer into mammalian cells. J Gene Med 1:4-12.
16. Fussenegger M. 2001. The impact of mammalian gene regulation concepts on functional genomic research, metabolic engineering, and advanced gene therapies. Biotechnol Prog 17:1-51.
17. Fussenegger M, Schlatter S, Datwyler D, Mazur X, Bailey JE. 1998. Controlled proliferation by multigene metabolic engineering enhances the productivity of Chinese hamster ovary cells. Nat Biotechnol 16:468-472.
18. Fussenegger M, Morris RP, Fux C, Rimann M, von Stockar B, Thompson CJ, Bailey JE. 2000. Streptogramin-based gene regulation systems for mammalian cells. Nat Biotechnol 18:1203-1208.
19. Fux C, Moser S, Schlatter S, Bailey JE, Fussenegger M. 2001. Streptogramin-and tetracycline-responsive dual regulated expression of p27(Kip1) sense and antisense enables positive and negative growth control of Chinese hamster ovary cells. Nucleic Acids Res 29:E19.
20. Geisse S, Henke M. 2005. Large-scale transient transfection of mammalian cells: A newly emerging attractive option for recombinant protein production. J Struct Funct Genomics 6:165-170.
21. Geserick C, Bonarius HP, Kongerslev L, Hauser H, Mueller PP. 2000. Enhanced productivity during controlled proliferation of BHK cells in continuously perfused bioreactors. Biotechnol Bioeng 69:266-274.
22. Gossen M, Bujard H. 1992. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 89:5547-5551.
23. Gossen M, Bujard H. 1995. Efficacy of tetracycline-controlled gene expression is influenced by cell type. Biotechniques 19:213-216.
24. Gossen M, Bujard H. 2002. Studying gene function in eukaryotes by conditional gene inactivation. Annu Rev Gene 36:153-173.
25. Graham FL, Smiley J, Russell WC, Nairn R. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36:59-74.
26. Grisshammer R, Tate CG. 1995. Overexpression of integral membrane proteins for structural studies. Q Rev Biophys 28:315-422.
27. Hartenbach S, Fussenegger M. 2005. Autoregulated, bidirectional and multicistronic gas-inducible mammalian as well as lentiviral expression vectors. J Biotechnol 120:83-98.
28. Howe JR, Skryabin BV, Belcher SM, Zerillo CA, Schmauss C. 1995. The responsiveness of a tetracycline-sensitive expression system differs in different cell lines. J Biol Chem 270:14168-14174.
29. Hug H, Costas M, Staeheli P, Aebi M, Weissmann C. 1988. Organization of the murine Mx gene and characterization of its interferon- and virus-inducible promoter. Mol Cell Biol 8:3065-3079.
30. Ibarra N, Watanabe S, Bi JX, Shuttleworth J, Al-Rubeai M. 2003. Modulation of cell cycle for enhancement of antibody productivity in perfusion culture of NS0 cells. Biotechnol Prog 19:224-228.
31. Ivanova L, Brandli J, Saudan P, Bachmann MF. 2005. Hybrid Sindbis/ Epstein-Barr virus episomal expression vector for inducible production of proteins. Biotechniques 39:209-212.
32. Kaufmann H, Mazur X, Marone R, Bailey JE, Fussenegger M. 2001. Comparative analysis of two controlled proliferation strategies regarding product quality, influence on tetracycline-regulated gene expression, and productivity. Biotechnol Bioeng 72:592-602.
33. Langer SJ, Schaack J, 1996. 293 cell lines that inducibly express high levels of adenovirus type 5 precursor terminal protein. Virology 221:172-179.
34. Lee WS, Kao CC, Bryant GO, Liu X, Berk AJ. 1991. Adenovirus E1A activation domain binds the basic repeat in the TATA box transcription factor. Cell 67:365-376.
35. Li Y, Graham C, Lacy S, Duncan AM, Whyte P. 1993. The adenovirus E1A-associated 130-kD protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A and E. Genes Dev 7:2366-2377.
36. Liu F, Green MR. 1990. A specific member of the ATF transcription factor family can mediate transcription activation by the adenovirus E1a protein. Cell 61:1217-1224.
37. Liu F, Green MR. 1994. Promoter targeting by adenovirus E1a through interaction with different cellular DNA-binding domains. Nature 368: 520-525.
38. Mazur X, Fussenegger M, Renner WA, Bailey JE. 1998. Higher productivity of growth-arrested Chinese hamster ovary cells expressing the cyclin-dependent kinase inhibitor p27. Biotechnol Prog 14:705-713.
39. Mazur X, Eppenberger HM, Bailey JE, Fussenegger M. 1999. A novel autoregulated proliferation-controlled production process using recombinant CHO cells. Biotechnol Bioeng 65:144-150.
40. Kip1-mediated controlled proliferation technology increases constitutive sICAM production in CHO-DUKX adapted for growth in suspension and serum-free media. Biotechnol Bioeng 79:619-627.
41. Meyer-Ficca ML, Meyer RG, Kaiser H, Brack AR, Kandolf R, Kupper JH. 2004. Comparative analysis of inducible expression systems in transient transfection studies. Anal Biochem 334:9-19.
42. Mueller PP, Schlenke P, Nimtz M, Conradt HS, Hauser H. 1999. Recombinant glycoprotein product quality in proliferation-controlled BHK-21 cells. Biotechnol Bioeng 65:529-536.
43. Nevins JR. 1992. E2F: A link between the Rb tumor suppressor protein and viral oncoproteins. Science 258:424-429.
44. No D, Yao TP, Evans RM. 1996. Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc Natl Acad Sci USA 93: 3346-3351.
45. Sang N, Caro J, Giordano A. 2002. Adenoviral E1A: Everlasting tool, versatile applications, continuous contributions and new hypotheses. Front Biosci 7:407-413.
46. Schlatter S, Bailey JE, Fussenegger M. 2001. Novel surface tagging technology for selection of complex proliferation-controlled mammalian cell phenotypes. Biotechnol Bioeng 75:597-606.
47. Schlatter S, Rimann M, Kelm J, Fussenegger M. 2002. SAMY, a novel mammalian reporter gene derived from Bacillus stearothermophilus alpha-amylase. Gene 282:19-31.
48. Sherr CJ, Roberts JM. 1999. CDK inhibitors: Positive and negative regulators of G1-phase progression. Genes Dev 13:1501-1512.
49. Tate CG, Haase J, Baker C, Boorsma M, Magnani F, Vallis Y, Williams DC. 2003. Comparison of seven different heterologous protein expression systems for the production of the serotonin transporter. Biochim Biophys Acta 1610:141-153.
50. Toyoshima H, Hunter T. 1994. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78:67-74.
51. Van Craenenbroeck K, Vanhoenacker P, Duchau H, Haegeman G. 2000. Molecular integrity and usefulness of episomal expression vectors derived from BK and Epstein-Barr virus. Gene 253:293-301.
52. Wang G, Miskimins R, Miskimins WK. 2000. Mimosine arrests cells in G1 by enhancing the levels of p27(Kip1). Exp Cell Res 254: 64-71.
53. CIP1. Biotechnol Bioeng 77:1-7.
54. Weber W, Fussenegger M. 2006. Pharmacologic transgene control systems for gene therapy. J Gene Med 8:535-556.
55. Weber W, Fux C, Daoud-el Baba M, Keller B, Weber CC, Kramer BP, Heinzen C, Aubel D, Bailey JE, Fussenegger M. 2002. Macrolide-based transgene control in mammalian cells and mice. Nat Biotechnol 20:901-907.
56. Weber W, Rimann M, Spielmann M, Keller B, Daoud-El Baba M, Aubel D, Weber CC, Fussenegger M. 2004. Gas-inducible transgene expression in mammalian cells and mice. Nat Biotechnol 22:1440-1444.
57. Weber W, Rimann M, de Glutz FN, Weber E, Memmert K, Fussenegger M. 2005. Gas-inducible product gene expression in bioreactors. Metab Eng 7:174-181.
58. Whyte P, Buchkovich KJ, Horowitz JM, Friend SH, Raybuck M, Weinberg RA, Harlow E. 1988. Association between an oncogene and an anti-oncogene: The adenovirus E1A proteins bind to the retinoblastoma gene product. Nature 334:124-129.
59. Zhao HF, Boyd J, Jolicoeur N, Shen SH. 2003. A coumermycin/novobiocin- regulated gene expression system. Hum Gene Ther 14:1619-1629.
60. Zhou Y, Ratner L. 2001. A novel inducible expression system to study transdominant mutants of HIV-1 Vpr. Virology 287:133-142.